At AACR19 were presenting 28 abstracts on our latest nextgeneration ImmunoOncology research. We are exploring multiple ways to activate the immune system to recognise respond and regain control of cancer.pic.twitter.comC8qLCqBBIF

At #AACR19, we’re presenting 28 abstracts on our latest next-generation #ImmunoOncology research. We are exploring multiple ways to activate the immune system to recognise, respond and regain control of #cancer.pic.twitter.com/C8qLCqBBIF

08:57 EDT 29 Mar 2019 | AztraZeneca

At #AACR19, we’re presenting 28 abstracts on our latest next-generation #ImmunoOncology research. We are exploring multiple ways to activate the immune system to recognise, respond and regain control of #cancer. pic.twitter.com/C8qLCqBBIF

More From BioPortfolio on "At #AACR19, we’re presenting 28 abstracts on our latest next-generation #ImmunoOncology research. We are exploring multiple ways to activate the immune system to recognise, respond and regain control of #cancer.pic.twitter.com/C8qLCqBBIF"